← Back to All Filings

Exelixis Director Sells $1.03M in Stock Post-Option Exercise

Low SignificanceNovember 13, 2025 at 7:32:43 PM EST

EXELIXIS, INC.

$EXEL4CIK: 0000939767

Subscribe to track EXEL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Exelixis Director Sells $1.03M in Stock Post-Option Exercise

Company: EXELIXIS, INC. (EXEL) Form: 4 | Filed: 2025/11/13 Significance: Low

Insider: Beckerle Mary C Title: Director

Transaction: • Type: Sell (following option exercise) • Shares: 24,622 • Price: ~$41.93 (avg) • Value: $1,032,412 • Owned After: 21,380

Key Insight: A Director exercised options and subsequently sold shares valued at over $1M. While the sale is immaterial to the company's $11.1B market cap, it represented over 53% of the insider's direct holdings, suggesting personal financial planning or diversification.

Market Context: The transaction is a common 'exercise-and-sell' maneuver and represents a negligible 0.009% of total shares outstanding, indicating no expected market impact.

Comprehensive Analysis

SEC Filing Analysis: EXELIXIS, INC. (EXEL)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A Director executed a common 'exercise-and-sell' transaction, liquidating shares worth approximately $1.03 million. While the sale constituted over 53% of the insider's personal holdings, its size is insignificant relative to the company's market capitalization.
  • Market Impact: Neutral. The transaction is too small to have a material impact on the stock.

Company Information

FieldValue
CompanyEXELIXIS, INC.
Ticker SymbolEXEL
CIK0000939767
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameBeckerle Mary C
CIK0001520181
Title/PositionDirector
RelationshipDirector

Transaction Details

This filing reports an option exercise followed by two separate sales of common stock on the same day. The details below aggregate the sales for a comprehensive view of the insider's disposition.

FieldValue
Form Type4
Transaction Date2025-11-11
Transaction CodeM / S (Option Exercise and Sale)
Security TypeCommon Stock
Shares Involved24,622 (Sold)
Price Per Share~$41.93 (Weighted Average Sale Price)
Total Value$1,032,411.72 (Total Sale Value)
Shares Owned After21,380
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,032,412
% of Market Cap0.0093%
Shares Transacted24,622
% of Shares Outstanding0.0091%
Post-Transaction Ownership21,380 shares (0.0079% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $1.03M sale is negligible for a company with an $11.1 billion market capitalization. It falls far below the 0.1% threshold for even moderate significance.
  • Ownership Concentration: The insider's post-transaction ownership of 21,380 shares is a very small fraction of the 269 million shares outstanding, indicating low ownership concentration.
  • Transaction Significance: The key insight is not the market impact but the personal one. The sale of 24,622 shares from a pre-sale position of 46,002 (post-exercise) represents a disposition of 53.5% of the insider's holdings. This is a substantial reduction for the individual, likely driven by diversification or profit-taking goals.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The total shares sold represent less than 0.01% of the company's shares outstanding. This volume is insufficient to influence price discovery. The nature of the transaction (exercise-and-sell) is routine and does not signal a change in the insider's fundamental outlook on the company.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size will be absorbed by daily trading volume without notice.
  • Sentiment Indicator: Neutral. This is a standard executive compensation-related transaction, not a discretionary trade based on new information.

Additional Context

Transaction Notes

  • Pattern: The filing demonstrates a classic 'exercise-and-sell' pattern where an insider exercises stock options and immediately sells the acquired shares, often to cover the exercise cost and taxes, while also realizing a profit.
  • Footnotes: Footnote F2 confirms one of the sales was executed at a weighted average price, a standard practice for large orders. Footnote F1 notes that the remaining shares owned include unvested Restricted Stock Units (RSUs).
Topics:#SECFiling#InsiderTrading#EXEL#Exelixis#Form4#InsiderSell#Biotech#StockMarket#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.